...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
【24h】

Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

机译:2019年冠状病毒疾病实验室诊断中的潜在预期和分析脆弱性(Covid-19)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A novel zoonotic coronavirus outbreak is spreading all over the world. This pandemic disease has now been defined as novel coronavirus disease 2019 (COVID-19), and is sustained by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current gold standard for the etiological diagnosis of SARS-CoV-2 infection is (real time) reverse transcription polymerase chain reaction (rRT-PCR) on respiratory tract specimens, the diagnostic accuracy of this technique shall be considered a foremost prerequisite. Overall, potential RT-PCR vulnerabilities include general preanalytical issues such as identification problems, inadequate procedures for collection, handling, transport and storage of the swabs, collection of inappropriate or inadequate material (for quality or volume), presence of interfering substances, manual errors, as well as specific aspects such as sample contamination and testing patients receiving antiretroviral therapy. Some analytical problems may also contribute to jeopardize the diagnostic accuracy, including testing outside the diagnostic window, active viral recombination, use of inadequately validated assays, insufficient harmonization, instrument malfunctioning, along with other specific technical issues. Some practical indications can hence be identified for minimizing the risk of diagnostic errors, encompassing the improvement of diagnostic accuracy by combining clinical evidence with results of chest computed tomography (CT) and RT-PCR, interpretation of RT-PCR results according to epidemiologic, clinical and radiological factors, recollection and testing of upper (or lower) respiratory specimens in patients with negative RT-PCR test results and high suspicion or probability of infection, dissemination of clear instructions for specimen (especially swab) collection, management and storage, together with refinement of molecular target(s) and thorough compliance with analytical procedures, including quality assurance.
机译:一种新的动物园冠状病毒爆发正在遍布世界各地。这种大流行病现已被定义为2019年(Covid-19)的新型冠状病毒疾病,并且由严重急性呼吸综合征冠状病毒2(SARS-COV-2)持续。由于目前的SARS-COV-2感染的病因诊断的金标准是(实时)逆转录聚合酶链反应(RRT-PCR)对呼吸道标本,这种技术的诊断准确性应被视为最重要的先决条件。总体而言,潜在的RT-PCR漏洞包括普通的预期问题,如识别问题,收集,处理,运输和储存的拭子的不足,收集不适当或不足的材料(质量或体积),存在干扰物质,手动误差以及特定方面,如样品污染和检测患者接受抗逆转录病毒治疗。一些分析问题也可能有助于危及诊断准确性,包括在诊断窗口外,有源病毒重组,使用不充分的验证的测定,互动,仪器故障的不充分,仪器发生故障以及其他特定技术问题。因此,可以确定一些实际适应症,以便通过将胸部计算机断层扫描(CT)和RT-PCR结果组合,通过将临床证据组合,根据流行病学,临床,通过将临床证据组合来识别诊断误差的风险来最小化诊断误差的风险。患有阴性RT-PCR测试结果和感染患者的患者上(或较低)呼吸样本的放射性因素,再注化和测试,以及感染的高疑似或感染概率,分布明确指令(特别是拭子)收集,管理和储存细化分子靶标和彻底遵守分析程序,包括质量保证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号